Theme: Inspiring Innovations and Interactive discussions on Leukemia and Hematologic Oncology care.

Hematologic Oncology 2017

Hematologic Oncology 2017

About conference

Conferenceseries LLC invites all the participants across the globe to attend the "11th International Conference on Leukemia and Hematologic Oncology” (Hematologic Oncology 2017) slated on October 05-06, 2017, London,UK

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

PeerPoint Medical Education Institute designates the live format for this educational activity for AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Hematologic Oncology 2017 will focus the latest and exciting innovations in allied areas of Leukemia and it will offer a unique opportunity for investigators from all over the world to meet, network, and perceive new scientific interactions. Leukemia is cancer of the blood cells. It starts in the bone marrow, the soft tissue inside most bones. Bone marrow is where blood cells are made. When you have leukemia, the bone marrow starts to make a lot of abnormal white blood cells, called leukemia cells. An estimated combined total of 156,420 people are expected to be diagnosed with leukemia in 2014. New cases of leukemia are expected to account for 9.4 percent of the estimated 1,665,540 new cancer cases diagnosed in 2014. 

Conferenceseries LLC is a pioneer and leading scientific event organizer, publishing around 700 Open access journals and conducting over 500 Scientific Meetings all over the globe annually with the support of more than 1000 scientific associations, 80,000 editorial board members, and 7.5 million followers to its credit.

Why to attend?

With members from around the world focused on learning about Leukemia and Hematologic Oncology; this is your best opportunity to reach the largest assemblage of participants from the Cancer community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new developments and research, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Leukemia diagnosis, treatment and surgery involved are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event

Target Audience:

Haematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from Academia and Research along with the industrial professionals from biomedical companies and healthcare sectors.





Sessions/Tracks

Conferenceseries LLC invites all the participants from all over the world to attend ’11th International Conference on Leukemia and Hematologic Oncology’ during October 05-06, 2017 in London,UK. The conference will be organized around the theme “

Hematologic Oncology 2017 welcomes haematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.

Track 1. Leukemia

       Leukaemia is a malignancy (cancer) of blood cells. In leukemia, abnormal blood cells are produced in the bone marrow. Leukemia involves the production of abnormal white blood cells the cells responsible for struggling infection. The abnormal cells in leukemia not function in the same way as normal white blood cells. The leukemia cells continue to develop and divide, finally crowding out the normal blood cells. The end result is that it becomes tough for the body to fight infections, control haemorrhage, and carriage oxygen.

Related Conferences

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

 

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event)  October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Track 2Hematology

Erythrocytes are also known as red blood cells which carry oxygen to the body and collect carbon dioxide from the body by the use of haemoglobin and its life span of 120 days. along the side the leucocytes helps in protecting the healthy cells because the W.B.C (leucocytes) act as the defending cells in protecting the immune system from the foreign cells. Formation of blood cellular components are called as Hematopoiesis and all the cellular blood components are derived from hematopoiesis stem cells in a healthy individual nearly 1011–1012  new blood cells are produced these help in steady peripheral circulation. If there is a increases of R.B.C in the body these causes polycythemia these can be measured through haematocrit level.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

 

Track 3.Hematologic-oncology

Hematologic Oncology is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood. Haematology includes the study of etiologist involves treating diseases that affect the production of blood and its components, such as blood cells, haemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. The laboratory work that goes into the study of blood is frequently performed by a medical technologist or medical laboratory scientist. Haematologists also conduct studies in oncology and work with oncologists, people who may specialize only in that field instead of both-the medical treatment of cancer. There are various disorders that people are affected by haematology. A few of these different types of blood conditions that are looked at include anemia, haemophilia, general blood clots, bleeding disorders, etc. As for related blood cancers such as leukemia, myeloma, and lymphoma, these are more serious cases that need to be diagnosed

Related Conferences:

Leukemia Conferences | Hematology ConferencesHematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Track 4. Blood Disorders and Blood oncology

Anemia is the most common type of blood disorder we treat. Patients with anemia have a deficiency of oxygen-rich red blood cells or their red blood cells do not function properly. A low level of hemoglobin, the iron-rich protein that carries the oxygen in red blood cells, signals the condition. Anemia can be chronic, or a temporary condition caused by other health issues, including cancer treatment, hepatitis C, and HIV/AIDS. Anemia frequently remains undiagnosed because it is an underlying condition of other health issues, including cancer, cardiovascular disease, diabetes, HIV/AIDS, inflammatory bowel disease, chronic kidney disease, and rheumatoid arthritis. Hemophilia is a rare, typically inherited blood disorder in which the blood does not properly clot and causes excessive bleeding, which can cause damage to organs, joints, and tissues. Patient may suffer excessive bleeding from the site of an injury or from internal bleeding. Clotting Disorders Hematologists also treat conditions related to the proteins that trigger bleeding and clotting, including thrombosis (clotting) and hemostasis (bleeding). Thrombosis refers to the formation of abnormal blood clots that become embedded in a major vein or artery, blocking blood circulation. Blood clots can cause pain, swelling, or warmth in the affected area, and can be life-threatening. Hemostasis is the process of controlling bleeding. Blood Cancers Cancerous blood conditions include leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Track 5. Leukemia immunology

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumors or malignancies). It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy (such as new vaccines and antibody therapies) and tumor marker-based diagnostic tests. 

Related Conferences:

 Leukemia Conferences | Hematology ConferencesHematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

 Track 6. Hemato Immunology &Stem Cell Research

Blood groups are of ABO type and but at present the Rh blood grouping of 50 well defined  antigens in which 5 are more important they are D,C,c,E and e and Rh factors are of Rh positive and Rh negative which refers to the D-antigen. These D-antigen helps in prevention of erythroblast fetalis lacking of Rh antigen it defined as negative and presences of Rh antigen in blood leads to positive these leads to rh incompatibility. The prevention treatment of diseases related to the blood is called as the Hematology. The hematologists conduct works on cancer to. The disorder of immune system leading to hypersensitivity is called as Clinical Immunology and the abnormal growth of an infection are known as Inflammation and the arise of an abnormal immune response to the body or an immune suppression are known as Auto immune disorder. The stem cell therapy is used to treat or prevent a disease or a condition mostly Bone marrow stem cell therapy is seen and recently umbilical cord therapy Stem cell transplantation strategies remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Track 7.Cancer and Alternative Medicine

Ayurvedic medicine is an ancient Indian system of medicine which began about 5,000 years ago. It is not just one treatment. It is a way of diagnosing illness and using a wide range of treatments and techniques. Herbal medicine uses plants, or mixtures of plant extracts, to treat illness and promote health. It aims to restore your body's ability to protect, regulate and heal itself. It is a whole body approach, so looks at your physical, mental and emotional well-being. It is sometimes called phytomedicine, phytotherapy or botanical medicine. Naturopathic doctors (NDs) believe that cancer arises from an imbalance that causes a systemic breakdown within the body. Homeopathy is based on the theory of treating like with like. So to treat an illness a homeopathic therapist (homeopath) uses tiny doses of a substance that in large doses would actually cause the symptoms of the illness.

Related Conferences:

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

.

Track 8. Haematological malignancies

Hematologic malignancies are forms of cancer that begins in the cells of blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Examples of hematologic cancer are acute and chronic leukemia, lymphomas, multiple myeloma and myelodysplastic syndromes. Myeloproliferative neoplasms, or MPNs, are hematologic cancers that arise from malignant hematopoietic myeloid progenitor cells in the bone marrow, such as the precursor cells of red cells, platelets and granulocytes.Included in the MPN disease spectrum are essential thrombocythemia, polycythemia Vera  and myelofibrosis . This scientific session will focus on all types of common or rare blood cancers such as acute promyelocytic leukemia (APL) and chronic myelomonocytic leukemia hairy cell leukemia (HCL), large granular lymphocytic leukemia (LGL), t-cell acute lymphoblastic leukemia (T-ALL), Non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma Multiple myeloma, Childhood Leukemia and Myelodysplastic–Myeloproliferative diseases.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Track 9.Haematological malignancies: Prognosis

The estimate of how the disease will go for a patient is called prognosis. There are many factors affect prognosis that include: the type of cancer and where it is in the body, the stage of the cancer, the cancer’s grade. Grade provides clues about how quickly the cancer is likely to grow and spread certain traits of the cancer cells, the age and how healthy body was before cancer & how successful is the treatment.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Track 10. Biomarkers

Protein Biomarkers can be used as biomarkers for early detection of cancers especially used for the identification of breast cancer. Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if a suspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a biopsy will be undertaken to confirm pancreatic cancer by H&E pathological analysis.  The presence of cancerous cells via pathology is very challenging due to high numbers of non-cancerous stromal infiltrating cells and administration of chemotherapy or enrolment into a clinical trial will only commence on definitive diagnosis of pancreatic cancer. These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 has been identified as a highly sensitive (98%) and specific (95%) IHC marker for pancreatic cancer and CRT is seeking a partner to develop an IHC based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

Track 11.Bone Marrow Transplantation and surgery

Bone Marrow Transplantation: A bone marrow transplant, also known as a haemopoietic stem cell transplant, replaces damaged bone marrow with healthy bone marrow stem cells. Bone marrow is a spongy tissue found in the hollow centres of some bones. It contains specialist stem cells, which produce the body's blood cells.

A biopsy is a sample of tissue taken from the body in order to examine it more closely. A doctor should recommend a biopsy when an initial test suggests that an area of tissue in the body isn't normal. Doctors may call that area of abnormal tissue a lesion, a tumour, or a mass.Topics of discussion in the scientific sessions are Bone Marrow Surgery, Stem Cell Surgery, Hematopoietic Cell Transplantations.

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK;

 Track 12.Advance in Bone Marrow Transplantation

An increasing number of diseases may be treated successfully by allogeneic bone marrow transplantation (BMT). Initially used for the treatment of immunodeficiency where a cell series or product is replaced, it has now become routine treatment for many forms of leukemia where the transplant provides the rescue after lethal marrow ablation. Recently, diseases such as thalassemia and other inherited metabolic diseases have also been treated by BMT. Formerly the problems of BMT were mainly concerned with graft versus host disease (GVHD) in HLA-matched transplants with HLA-mismatched ones not being possible as GVHD was usually fatal. Since the development of techniques for T cell removal the incidence of GVHD has greatly diminished. T cell removal has also allowed HLA haploidentical mismatched grafts to be performed successfully for immunodeficiency, but there is still a high graft rejection rate in leukemia. 

Related Conferences: 

Leukemia Conferences | Hematology Conferences | Hematologic Oncology Conferences

2nd Cancer Diagnostics Conference& Expo May 8-10,2017 Barcelona,Spain; 8th International Conference on Biomarkers  & Clinical Research December 05-07, 2016 Philadelphia, Pennsylvania,USA.14th Asia Pacific Oncologists Annual Meeting November 23-25,2017 Melbourne, Australia.7th World Hematologists Congress May 08-09, 2017 Barcelona, Spain. 6th World Congress On Breast Cancer (10Plenary Forums - 1Event) October 16-18, 2017 San Francisco, USA. 19th World Cancer Conference Nov 21-23, 2017 London, UK. 4th Gynecologic Cancer Conference Sep 5-6, 2017 London, UK; 8th International Conference on Blood Cancer & Treatment June 26-27, 2017 London, UK. 9th International Conference and Expo on Molecular & Cancer Biomarkers August 23-24, 2017 Birmingham, UK.

 





Past Conference Report

Hematologic Oncology 2016

The International conference on leukemia and Hematologic Oncology convoked by Conference Series LLC during October17-18, 2016 was successfully held at Rome, Italy with a theme “Solution Eradicate to Hematologic Oncology” was a great success where eminent keynote speakers from various reputed institutions with their resplendent presence addressed the gathering.

Thanks to all our momentous speakers, conference attendees who contributed towards the successful run of the conference.

Hematologic Oncology 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields of Leukemia, Hematologic Oncology, Haematology, Paediatric and Hematologic Oncology.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

·         Leukemia

·         Hemotology

·         Hematologic-oncology

·         Oncology

·         Paediatric Oncology

·         Clinical Oncology

·         Oncologists

·         Blood Disorders and Blood oncology

·         Leukemia Causes and symptoms

·         Leukemia Pathophysiology

·         Leukemia risk factors

·         Leukemia:Staging

·         Leukemia: Diagnosis

·         Leukemia immunology

·         Oncology Case Report

·         Hemato Immunology &Stem Cell Research

·         Cancer and pharmacology

·         Cancer: Treatment and Therapy

·         Cancer :Diagnostics and Staging

·         Cancer and Alternative Medicine

·         Haematological malignancies

·         Haematological malignancies: Prognosis

·         Childhood Hematological Cancers

·         Biomarkers

·         Leukemia :Treatments and care

·         Bone Marrow Transplantation and surgery

·         Advance in Bone Marrow Transplantation

·         Cancer Clinical Trials

Hematologic Oncology 2016 Organizing Committee would like to thank the Moderator of the conference, Jan Jacques Michiels, Goodheart Institute & Foundation in Nature Medicine & Health,Netherlands, who has contributed a lot for the smooth functioning of this event.

Our special thanks to David J Bearss, Tolero Pharmaceuticals, USA for his special participation as Key Note Speaker titled “Sequential treatment of AML patients with Alvocidib followed by Cytarabine and Mitoxantrone is highly effective through a mechanism dependent on MCL1 expression and function” which marked the special attraction at the conference.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Symposium and Special sessions:

Chronic lymphocytic leukemia: Risk factors and complications & The Diagnostic and prognostic value of CD38 and CD49d Expressions in chronic lymphocytic leukemia- Olfat M Hendy, Menoufia University, Egypt.

Diagnosis and treatment of DVT and prevention of DVT recurrence and the PTS: Bridging the gap between DVT and PTS in the primary care setting or outpatient ward - Jan Jacques Michiels, Good heart Institute, Netherlands.

Inhibition of AXL kinase reverses the mesenchymal phenotype in leukemia cells through the disruption of retinoic acid signalling - Steven L. Warner, Tolero Pharmaceuticals, Inc., USA

Conference Series LLC is privileged to felicitate Hematologic Oncology 2016 Organizing Committee, Chairs & Co-Chairs who supported for the success of this event. Conference Series LLC would like to thank every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Hematologic Oncology.

With the valuable feedback received from the participants of Hematologic Oncology 2016,Conference Series LLC is glad to announce the commencement of “11th International conference on leukemia and Hematologic Oncology  during December 04-05, 2017 Madrid, Spain. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of managing Leukemia and Hematologic Oncology and its concomitant risk factors.

Let us meet again @ Hematologic Oncology 2017

 


Past Reports  Gallery  



Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date October 05-06,2017
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity
Poster Opportunity Available

Conferenceseries Destinations